Regular Article
Metalloproteases and inhibitors in arthritic diseases

https://doi.org/10.1053/berh.2001.0195Get rights and content

Abstract

Controlling degradation of the extracellular matrix is crucial in arthritic diseases such as osteoarthritis (OA) and rheumatoid arthritis (RA), as conventional treatments do not positively affect the structural properties of the articular tissues. Metalloproteases, a family of zinc-dependent enzymes, and more specifically the matrix metalloproteases (MMPs), play a premier role in joint articular tissue degeneration. Additional enzymes of the metalloprotease family, such as the membrane-type metalloproteases (MT-MMPs) and the adamalysins that include the ADAMs and the ADAMTS families, have also been found to be involved in these disease processes. At present, therapeutic intervention based on the inhibition of metalloproteases, and more particularly of the MMPs, is under intensive investigation, and several MMP inhibitors are in clinical development. Currently, MMP inhibitors are exemplified by several chemical classes: hydroxamic acids, carboxylic acids and thiols. One key issue in the clinical development of MMP inhibitors relates to whether broad-spectrum inhibitors active against a range of different enzymes or selective inhibitors targeted against a single enzyme or particular subset of the MMPs represents the optimal strategy. In this chapter, we address the different metalloprotease enzymes and sub-families and their implication in arthritic diseases. Furthermore, we assess physiological and chemical metalloprotease inhibitors, and for the latter, the current inhibitory classes of compounds being studied.

References (66)

  • JT Downs et al.

    Analysis of collagenase-cleavage of type II collagen using a neoepitope ELISA

    Journal of Immunological Methods

    (2001)
  • CL Curtis et al.

    n-3 fatty acids specifically modulate catabolic factors involved in articular cartilage degradation

    Journal of Biological Chemistry

    (2000)
  • EW Humke et al.

    ICEBERG: a novel inhibitor of interleukin-1 beta generation

    Cell

    (2000)
  • JP Pelletier et al.

    Etiopathogenesis of osteoarthritis

  • TE Hardingham et al.

    Proteoglycans: many forms and many functions

    FASEB Journal

    (1992)
  • JF Woessner

    Matrix metalloproteinases and their inhibitors in connective tissue remodelling

    FASEB Journal

    (1991)
  • H Nagase

    Activation mechanisms of matrix metalloproteinases

    Biological Chemistry

    (1997)
  • JP Martel-Pelletier et al.

    Wanted–the collagenase responsible for the destruction of the collagen network in human cartilage!

    British Journal of Rheumatology

    (1996)
  • F Moldovan et al.

    Collagenase-3 (matrix metalloprotease 13) is preferentially localized in the deep layer of human arthritic cartilage in situ: in vitro mimicking effect by transforming growth factor beta

    Arthritis & Rheumatism

    (1997)
  • JC Fernandes et al.

    Collagenase-1 and collagenase-3 synthesis in normal and early experimental osteoarthritic canine cartilage: an immunohistochemical study

    Journal of Rheumatology

    (1998)
  • H Nagase et al.

    Matrix metalloproteinases

    Journal of Biological Chemistry

    (1999)
  • T Pap et al.

    Differential expression pattern of membrane-type matrix metalloproteinases in rheumatoid arthritis

    Arthritis & Rheumatism

    (2000)
  • ML Moss et al.

    Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha

    Nature

    (1997)
  • T Itai et al.

    Processing of tumor necrosis factor by the membrane-bound TNF-alpha-converting enzyme, but not its truncated soluble form

    European Journal of Biochemistry

    (2001)
  • M Tortorella et al.

    The thrombospondin motif of aggrecanase-1 (ADAMTS-4) is critical for aggrecan substrate recognition and cleavage

    Journal of Biological Chemistry

    (2000)
  • MD Tortorella et al.

    Purification and cloning of aggrecanase-1: a member of the ADAMTS family of proteins

    Science

    (1999)
  • MW Lark et al.

    Aggrecan degradation in human cartilage. Evidence for both matrix metalloproteinase and aggrecanase activity in normal, osteoarthritic, and rheumatoid joints

    Journal of Clinical Investigation

    (1997)
  • DK Miller et al.

    Purification and characterization of active human interleukin-1 beta-converting enzyme from THP.1 monocytic cells

    Journal of Biological Chemistry

    (1993)
  • N Saha et al.

    Interleukin-1beta-converting enzyme/caspase-1 in human osteoarthritic tissues: localization and role in the maturation of interleukin-1beta and interleukin-18

    Arthritis & Rheumatism

    (1999)
  • M Laiho et al.

    Growth factors in the regulation of pericellular proteolysis: a review

    Cancer Research

    (1989)
  • MP Vincenti et al.

    Regulating expression of the gene for matrix metalloproteinase-1 (collagenase): mechanisms that control enzyme activity, transcription, and mRNA stability

    Critical Reviews in Eukaryotic Gene Expression

    (1996)
  • N Malik et al.

    Activation of human monocytes through CD40 induces matrix metalloproteinases

    Journal of Immunology

    (1996)
  • Cited by (0)

    View full text